Skip to Content
Merck
CN

278858

3-Iodo-4-methylbenzoic acid

97%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
IC6H3(CH3)CO2H
CAS Number:
Molecular Weight:
262.04
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
97%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

97%

form

solid

mp

210-212 °C (lit.)

SMILES string

Cc1ccc(cc1I)C(O)=O

InChI

1S/C8H7IO2/c1-5-2-3-6(8(10)11)4-7(5)9/h2-4H,1H3,(H,10,11)

InChI key

LDDHMKANNXWUAK-UHFFFAOYSA-N

Application

3-Iodo-4-methylbenzoic acid has been used in the preparation of:
  • unlabeled N-succinimidyl 4-guanidinomethyl-3-iodobenzoate (SGIMB)
  • boc-protected derivative of SGIMB (Boc-SGMIB)


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Ganesan Vaidyanathan et al.
Nature protocols, 2(2), 282-286 (2007-04-05)
This protocol describes a detailed procedure for the synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate ([*I]SGMIB), an agent useful in the radio-iodination of proteins, including monoclonal Abs, and peptides that undergo internalization after receptor or antigen binding. In this procedure, the tin precursor
G Vaidyanathan et al.
Bioconjugate chemistry, 12(3), 428-438 (2001-05-17)
The objective of this study was to develop an acylation agent for the radioiodination of monoclonal antibodies that would maximize retention of the label in tumor cells following receptor- or antigen-mediated internalization. The strategy taken was to add a polar



Global Trade Item Number

SKUGTIN
278858-5G04061832491660
278858-25G04061832491653